Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epigenetics
Biotech
Omega halts sole clinical-stage asset to focus on 3 programs
Omega is halting work on its clinical-stage candidate as part of a strategic refocus centered on three preclinical epigenomic controller programs.
James Waldron
Nov 15, 2024 5:33am
Epigenetic cancer drug duo packs punch against colorectal cancer
Apr 1, 2024 3:20pm
Epigenetic silencing lasts in mice, Chroma-sponsored study shows
Feb 28, 2024 11:00am
Tune’s HBV therapy hits the right notes in cells and mice
Dec 7, 2023 2:05pm
Chroma bags $135M to bolster epigenetic-focused platform
Feb 28, 2023 6:10pm
CRISPR pioneer's Epic bags $55M to use tiny Cas for epigenetics
Jul 12, 2022 6:00am